Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | pTVG-HP plasmid DNA vaccine |
Synonyms | |
Therapy Description |
pTVG-HP plasmid DNA vaccine contains human prostatic acid phosphatase (PAP)-encoding plasmid DNA, which induces cytotoxic immune response towards tumor cells expressing PAP (PMID: 17102977). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
pTVG-HP plasmid DNA vaccine | pTVG-HP plasmid DNA vaccine contains human prostatic acid phosphatase (PAP)-encoding plasmid DNA, which induces cytotoxic immune response towards tumor cells expressing PAP (PMID: 17102977). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT01706458 | Phase II | pTVG-HP plasmid DNA vaccine Sipuleucel-T | Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer | Completed | USA | 0 |